VAMP1 and early-onset autosomal dominant Alzheimer disease: These data suggest that while the contribution of VAMP1 genotype to Alzheimer’s disease risk is at best modest, what is clear is that control of the expression of this particular SNARE can affect a key cellular process in the pathophysiology of Alzheimer’s disease by altering the neuronal secretion of the Aβ peptide.